Company Filing History:
Years Active: 2015
Title: Chetan Surjitsingh Puri: Innovator in Tyrosine Kinase Inhibitors
Introduction
Chetan Surjitsingh Puri, based in Baroda, India, is a noteworthy inventor recognized for his contributions in the field of medicinal chemistry. He has secured one patent that showcases his innovative approach to developing pharmaceutical compounds aimed at addressing serious health conditions.
Latest Patents
Chetan's patent, titled "Diarylacetylene hydrazide containing tyrosine kinase inhibitors," relates to novel diarylacetylene hydrazide compounds characterized by their ability to function as tyrosine kinase inhibitors. The present invention discusses the process for the preparation of these compounds and emphasizes their application in formulating pharmaceutical compositions for the therapeutic treatment of disorders linked to tyrosine kinases in warm-blooded animals.
Career Highlights
Chetan Puri works at Sun Pharma Advanced Research Company Limited, an esteemed organization focused on pharmaceutical research and innovation. His role at the company reflects his commitment to advancing medical science and contributing to the development of effective therapeutic drugs.
Collaborations
Throughout his career, Chetan has collaborated closely with fellow innovators, including Prabal Sengupta and Hemant Ashvinbhai Chokshi. These partnerships highlight the importance of teamwork in fostering innovation and bringing ideas to fruition within the pharmaceutical research community.
Conclusion
Chetan Surjitsingh Puri stands out as an influential inventor whose work on tyrosine kinase inhibitors has the potential to impact therapeutic practices significantly. With his innovative spirit and dedication to research, he continues to contribute to advancements in the field of pharmaceuticals, improving health outcomes for countless individuals.